Eqis Capital Management, Inc. Integra Lifesciences Holdings Corp Transaction History

Eqis Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$64.97 - $76.19 $203,680 - $238,855	-3,135 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$66.79 - $76.63 $13,157 - $15,096	197 Added 6.71%	3,135 $214,000
Q1 2021 May 14, 2021	BUY	$62.63 - $71.15 $184,006 - $209,038	2,938 New	2,938 $203,000
Q4 2019 Jan 24, 2020	SELL	$55.73 - $62.49 $255,633 - $286,641	-4,587 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$53.29 - $64.59 $244,441 - $296,274	4,587 New	4,587 $276,000
Q2 2018 Jul 27, 2018	SELL	$54.05 - $67.23 $437,048 - $543,621	-8,086 Closed	0 $0
Q1 2018 Apr 06, 2018	BUY	$46.55 - $57.38 $376,403 - $463,974	8,086 New	8,086 $447,000

241

75.3M

585K

21.3K

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.